Phase III Study to Evaluate Efficacy and Safety of Andecaliximab With mFOLFOX6 as First-Line Treatment in Patients With Advanced Gastric or GEJ Adenocarcinoma (GAMMA-1)

Shah, MA; Bodoky, G; Starodub, A; Cunningham, D; Yip, D; Wainberg, ZA; Bendell, J; Thai, D; He, JY; Bhargava, P; Ajani, JA

Shah, MA (corresponding author), NewYork Presbyterian Hematol Oncol, Weill Cornell Med, 1305 York Ave,Room Y1247, New York, NY 10021 USA.

JOURNAL OF CLINICAL ONCOLOGY, 2021; 39 (9):

Abstract

PURPOSE Andecaliximab (ADX) is a monoclonal antibody that inhibits matrix metalloproteinase 9, an extracellular enzyme involved in matrix remodeling, ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索